UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1244 Immunocytochemical detection of hepatocellular carcinoma micrometastases using HEP PAR-1 monoclonal antibody in patients undergoing liver transplantation

Hepatology (Baltimore, Md.), 2003, Vol.38, p.760-760

2003

Volltextzugriff (PDF)

137 Clinical potential of mutant ras

Leukemia research, 1997-04, Vol.21 (1), p.S35-S35

Mufti, Ghulam J.

1997

Volltextzugriff (PDF)

149 Treatment strategies in MDS: Who and how should be treated?

Leukemia research, 1997-04, Vol.21 (1), p.S39-S39

Mufti, Ghulam J.

1997

Volltextzugriff (PDF)

IL‐17‐producing CD4+ T cells, pro‐inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome

British journal of haematology, 2009-04, Vol.145 (1), p.64-72

2009

Volltextzugriff (PDF)

IL-2/B7.1 (CD80) Fusagene Transduction of AML Blasts by a Self-Inactivating Lentiviral Vector Stimulates T Cell Responses in Vitro: a Strategy to Generate Whole Cell Vaccines for AML

Molecular therapy, 2005-01, Vol.11 (1), p.120-131

2005

Volltextzugriff (PDF)

5-Azacytidine in the Treatment of High Risk Myelodysplastic Syndromes: Clinical Response Can Occur without Demethylation of the CDKN2B, CDKN1A or TP73 Gene Promoters

Blood, 2004-11, Vol.104 (11), p.2369-2369

2004

Volltextzugriff (PDF)

5-Azacytidine Specifically Depletes Regulatory T Cells (Tregs) in Myelodysplastic Syndrome (MDS) Patients

Blood, 2011-11, Vol.118 (21), p.787-787

2011

Volltextzugriff (PDF)

IL-6 Production by B-CLL Cells Plays a Critical Role in the Inhibition of T Cell Activation and Proliferation and Promotes a Th2 Response in Normal T Lymphocytes

Blood, 2006-11, Vol.108 (11), p.2808-2808

2006

Volltextzugriff (PDF)

The Acquired CD40L Deficiency in B-CLL Is Reversible and Due To Contact Dependant and Independent Factors

Blood, 2004-11, Vol.104 (11), p.2813-2813

2004

Volltextzugriff (PDF)

Acquired Somatic Uniparental Disomy is a Chromosomal Defect Important in Predicting Treatment Responses and Survival Outcomes in MDS, MDS/MPN and Secondary AML

Blood, 2009-11, Vol.114 (22), p.2630-2630

2009

Volltextzugriff (PDF)

Acute Lymphoblastic Leukemia

Advances in Malignant Hematology, 2011, p.228-243

2011

Volltextzugriff (PDF)

Acute myeloid leukaemia presenting with mediastinal myeloid sarcoma: Report of three cases and review of literature

Leukemia & lymphoma, 2007-02, Vol.48 (2), p.290-294

2007

Volltextzugriff (PDF)

Acute Myeloid Leukemia

Advances in Malignant Hematology, 2011, p.103-126

2011

Volltextzugriff (PDF)

Acute Promyelocytic Leukemia

Advances in Malignant Hematology, 2011, p.127-142

2011

Volltextzugriff (PDF)

Adult T-Cell Leukemia/Lymphoma in London: Clinical Experience of 21 Cases

Leukemia & lymphoma, 1998-09, Vol.31 (1-2), p.177-185

1998

Volltextzugriff (PDF)

Advances in Allogeneic Hematopoietic Cell Transplantation: Progress in Transplantation Technology and Disease‐Specific Outcomes

Advances in Malignant Hematology, 2011, p.367-383

2011

Volltextzugriff (PDF)

Advances in Malignant Hematology

1. Aufl., 2011

Volltextzugriff (PDF)

Adverse Effect of Very Poor Cytogenetics and Monosomal Karyotype On Outcomes Following T-Deplete Reduced Intensity Conditioned Stem Cell Transplant for MDS and AML

Blood, 2012-11, Vol.120 (21), p.3141-3141

2012

Volltextzugriff (PDF)

Age Distribution and Pattern of Myeloid Marrow Mutations in Patients (pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS) after Failure of Hypomethylating Agents (HMAs)

Blood, 2015-12, Vol.126 (23), p.5257-5257

2015

Volltextzugriff (PDF)

AKT1 (E17K) Mutation in Pancreatic Cancer

Technology in cancer research & treatment, 2008-10, Vol.7 (5), p.407-408

2008

Volltextzugriff (PDF)

Alemtuzumab-Based Reduced-Intensity Conditioning Allogeneic Transplantation for Myeloma and Plasma Cell Leukemia – A Single-Institution Experience

Clinical lymphoma, myeloma and leukemia, 2011-04, Vol.11 (2), p.242-245

2011

Volltextzugriff (PDF)

Alemtuzumab-Based RIC HSCT with Pre-Emptive DLI as An Effective Strategy to Achieve Long-Term Disease Remission In Patients with High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML)

Blood, 2010-11, Vol.116 (21), p.1304-1304

2010

Volltextzugriff (PDF)

Alemtuzumab Used with Fludarabine and Cyclophosphamide (FCC) for Stem Cell Transplantation in Acquired Aplastic Anemia Is Associated with a Low Risk of Graft Versus Host Disease and Viral Infections and with Sustained Engraftment

Blood, 2009-11, Vol.114 (22), p.1084-1084

2009

Volltextzugriff (PDF)

Alemtuzumab versus anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning

European journal of haematology, 2018-10, Vol.101, p.466-474

2018

Volltextzugriff (PDF)

Alemtuzumab vs anti‐thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning

European journal of haematology, 2018-10, Vol.101 (4), p.466-474

2018

Volltextzugriff (PDF)

1 – 25 von 570

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(501)
Mit Volltextzugriff
(534)

Publikationsform

Artikel
(535)
Buchkapitel
(31)
Berichte
(3)
Bücher
(1)

Sprache

Englisch
(570)

Erscheinungsjahr

n.n

Thema

Science & Technology
(245)
Humans
(244)
Life Sciences & Biomedicine
(243)
Hematology
(170)
Male
(130)
Middle Aged
(126)
Female
(124)
Adult
(114)
Aged
(108)
Biological And Medical Sciences
(98)
Medical Sciences
(93)
Hematologic And Hematopoietic Diseases
(74)
Oncology
(70)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(66)
Myelodysplastic Syndromes
(49)
Aged, 80 And Over
(44)
Treatment Outcome
(42)
Myelodysplastic Syndromes - Genetics
(41)
Adolescent
(37)
Myelodysplastic Syndromes - Pathology
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

1244 Immunocytochemical detection of hepatocellular carcinoma micrometastases using HEP PAR-1 monoclonal antibody in patients undergoing liver transplantation

137 Clinical potential of mutant ras

149 Treatment strategies in MDS: Who and how should be treated?

IL‐17‐producing CD4+ T cells, pro‐inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome

IL-2/B7.1 (CD80) Fusagene Transduction of AML Blasts by a Self-Inactivating Lentiviral Vector Stimulates T Cell Responses in Vitro: a Strategy to Generate Whole Cell Vaccines for AML

5-Azacytidine in the Treatment of High Risk Myelodysplastic Syndromes: Clinical Response Can Occur without Demethylation of the CDKN2B, CDKN1A or TP73 Gene Promoters

5-Azacytidine Specifically Depletes Regulatory T Cells (Tregs) in Myelodysplastic Syndrome (MDS) Patients

IL-6 Production by B-CLL Cells Plays a Critical Role in the Inhibition of T Cell Activation and Proliferation and Promotes a Th2 Response in Normal T Lymphocytes

The Acquired CD40L Deficiency in B-CLL Is Reversible and Due To Contact Dependant and Independent Factors

Acquired Somatic Uniparental Disomy is a Chromosomal Defect Important in Predicting Treatment Responses and Survival Outcomes in MDS, MDS/MPN and Secondary AML

Acute Lymphoblastic Leukemia

Acute myeloid leukaemia presenting with mediastinal myeloid sarcoma: Report of three cases and review of literature

Acute Myeloid Leukemia

Acute Promyelocytic Leukemia

Adult T-Cell Leukemia/Lymphoma in London: Clinical Experience of 21 Cases

Advances in Allogeneic Hematopoietic Cell Transplantation: Progress in Transplantation Technology and Disease‐Specific Outcomes

Advances in Malignant Hematology

Adverse Effect of Very Poor Cytogenetics and Monosomal Karyotype On Outcomes Following T-Deplete Reduced Intensity Conditioned Stem Cell Transplant for MDS and AML

Age Distribution and Pattern of Myeloid Marrow Mutations in Patients (pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS) after Failure of Hypomethylating Agents (HMAs)

AKT1 (E17K) Mutation in Pancreatic Cancer

Alemtuzumab-Based Reduced-Intensity Conditioning Allogeneic Transplantation for Myeloma and Plasma Cell Leukemia – A Single-Institution Experience

Alemtuzumab-Based RIC HSCT with Pre-Emptive DLI as An Effective Strategy to Achieve Long-Term Disease Remission In Patients with High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML)

Alemtuzumab Used with Fludarabine and Cyclophosphamide (FCC) for Stem Cell Transplantation in Acquired Aplastic Anemia Is Associated with a Low Risk of Graft Versus Host Disease and Viral Infections and with Sustained Engraftment

Alemtuzumab versus anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning

Alemtuzumab vs anti‐thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning

Suchergebnisse filtern